| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11918559 | PRIMUS PHARMS | Reduced dose metaxalone formulations |
Jul, 2039
(15 years from now) | |
Metaxalone is owned by Primus Pharms.
Metaxalone contains Metaxalone.
Metaxalone has a total of 1 drug patent out of which 0 drug patents have expired.
Metaxalone was authorised for market use on 01 June, 2015.
Metaxalone is available in tablet;oral dosage forms.
The generics of Metaxalone are possible to be released after 29 July, 2039.
Drugs and Companies using METAXALONE ingredient
Market Authorisation Date: 01 June, 2015
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
METAXALONE family patents
